What question did this study set out to answer?

The aim is to evaluate the impact of pharmacist-led management on the effectiveness of GLP-1 and GIP/GLP-1 receptor agonists in controlling blood sugar levels.

March 25, 2026American Journal of Health-System Pharmacy

Pharmacist-led management of GLP-1 and GIP/GLP-1 receptor agonists in type 2 diabetes mellitus

View Full Paper

Ask AI

Bookmark

The aim is to evaluate the impact of pharmacist-led management on the effectiveness of GLP-1 and GIP/GLP-1 receptor agonists in controlling blood sugar levels.
Comparison of pharmacist-led management versus usual care
Assessment of HbA1c levels
Focus on patients with type 2 diabetes
Pharmacist-led management resulted in a greater reduction in HbA1c levels compared to usual care
Demonstrated improvement in blood sugar control

Implication

Pharmacist-led management improves HbA1c in individuals with type 2 diabetes, indicating effective intervention strategies.

Abstract

Pharmacist-led management of GLP-1 RA or GIP/GLP-1 RA therapy resulted in a greater improvement in HbA1c when compared to usual care.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Park et al. (2026) studied this question.

synapsesocial.com/papers/69c37b11b34aaaeb1a67d225 https://doi.org/10.1093/ajhp/zxag086

View Full Paper

Ask AI

Bookmark

Implication

Pharmacist-led management improves HbA1c in individuals with type 2 diabetes, indicating effective intervention strategies.

Abstract

Pharmacist-led management of GLP-1 RA or GIP/GLP-1 RA therapy resulted in a greater improvement in HbA1c when compared to usual care.

Pharmacist-led management of GLP-1 and GIP/GLP-1 receptor agonists in type 2 diabetes mellitus

Key Points

Implication

Abstract

Discussion

Cite This Study

Pharmacist-led management of GLP-1 and GIP/GLP-1 receptor agonists in type 2 diabetes mellitus

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading